MolecuLight Inc. announced the publication of “Skin Pigmentation Impacts the Clinical Diagnosis of Wound Infection: Imaging of Bacterial Burden to Overcome Diagnostic Limitations”1 in the Journal of Racial and Ethnic Health Disparities.
AMO Pharma Limited announced completion of treatment for the final patient enrolled in the company’s REACH-CDM clinical study of the investigational therapy AMO-02.
Micropep Technologies, the global leader in micropeptide technology, announced successful efficacy results of its new biofungicide micropeptide ingredient during the 2022 field testing season.
Micropep Demonstrates Excellent Field Efficacy for New Micropeptide Active Ingredient Read More »
Danaher Corporation announced results for the first quarter 2023. Net earnings refer to net earnings attributable to common shareholders.
Adcentrx Therapeutics, a biotechnology company dedicated to revolutionizing Antibody-Drug Conjugate therapeutics for cancer and other life-threatening diseases, announces the closing of a $38 million Series A+ financing.
FineHeart S.A announced that its first two patents have been granted in China by the CNIPA – China National Intellectual Property Administration -.
FineHeart Granted First Two Patents in China for the FLOWMAKER® Read More »
Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the first quarter ended March 31, 2023 on Tuesday, May 9, 2023 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. BST to discuss these financial results and provide a
OKYO Pharma Limited announces the activation of the first clinical trial site in the U.S. for its phase 2, multi-center, randomized, double-blinded, placebo-controlled trial, evaluating the efficacy and safety of OK-101 ophthalmic solution in subjects with dry eye disease.
Santhera Pharmaceuticals and ReveraGen BioPharma, Inc announce the successful completion of the mid-cycle review meeting by the U.S. Food and Drug Administration of the new drug application for vamorolone for the treatment of Duchenne muscular dystrophy.
Vamorolone NDA mid-cycle review meeting by FDA completed Read More »
Al hablar de una resonancia y radiografía de pie nos referimos a técnicas médicas que se toman en cuenta a la hora de querer conocer el estado de los huesos del pie. Generalmente, cuando se acude para realizar alguno de estos estudios es porque en el exterior se observa que hay …
Resonancia y radiografía de pie: lo que debes saber Read More »
